InvestorsHub Logo
Followers 5
Posts 528
Boards Moderated 0
Alias Born 07/16/2013

Re: investorluck post# 59789

Sunday, 03/18/2018 2:41:15 PM

Sunday, March 18, 2018 2:41:15 PM

Post# of 108192
"LB-150 / 17 - Neoantigens that fail to elicit measurable T cell responses following peptide immunization can control tumor growth when delivered using a Listeria-based immunotherapy platform".

It will be interesting to see how this compares to the peptide-based personalized neoantigen vaccines.

I am not a trained financial professional, and all posts are my bar stool amateur opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News